Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid and Chlorhexidine Gel on Alveolar Osteitis Incidence
NCT06435832Active, not recruiting
- Sponsor
- Recep Tayyip Erdoğan University
- Start
- May 2024
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tranexamic acid and chlorhexidine + cymenol gel in alveolar osteitis (AO) (3 arms), sponsored by Recep Tayyip Erdoğan University. Primary endpoints: Pain levels at 7 days, Edema levels at 7 days and 3 more. Started May 2024; status: active, not recruiting.
02
Drugs
tranexamic acidchlorhexidine + cymenol gel
03
Conditions
alveolar osteitis (AO)
Beyond the preview
Go deeper on NCT06435832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06435832.